CLINICAL_TRIALS
trial_result
· 2024-12-09
Clinical Trial Update: Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment [Phase 1]
Summary
A Phase 1 study assessing pharmacokinetics and safety of a single dose of GZR4 in subjects with renal impairment, in the context of diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes | Phase 1 | Status: COMPLETED